N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332053713 (In-Stock Building Blocks)
- IUPAC Name
- N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide
- Mol formula
- C12H13N3O3S
- Mol weight
- 279 Da
- Catalog Number(s)
- BBLS21332053713, EN300-54823331, bbls21332053713
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.84
- Heavy atoms count
- 19
- Rotatable bond count
- 5
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.166
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide (C12H13N3O3S) - CSSB21332053713](/st/structure/200/b56b611a5c0b20eb39d655e4af8e93a0/C%253DCS%2528%253DO%2529%2528%253DO%2529NCCC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png "C12H13N3O3S")
- Zoom the structure
- CSSB21332053713
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]ethene-1-sulfonamide - CSSB21332167021](/st/structure/200/206a1004fdd927941b381524f9bfd415/CC%2528CC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]ethene-1-sulfonamide - CSSB21332124556](/st/structure/200/4bac37bb44ecfe626493c1a0954ed204/CC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{2-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332124092](/st/structure/200/60e22a5ba512e7c8741ab0cc39e7abfb/ClC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528CCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DN1.png)
![Chemical structure of N-{2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332126721](/st/structure/200/85f80a97a29363c21532cf4d8271be1f/ClC1%253DCC%253DCC%2528%253DC1%2529C1%253DNOC%2528CCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DN1.png)
![Chemical structure of N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332166559](/st/structure/200/d6f186e508250f9297478561a86992c2/BrC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528CCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DN1.png)
Similarity Analogs
![Chemical structure of N-[3-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]ethene-1-sulfonamide - CSSB21332166474](/st/structure/200/f59d14463e12f2fb7930fc58abb21d4d/C%253DCS%2528%253DO%2529%2528%253DO%2529NCCCC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB21332053700](/st/structure/200/5e8f8d928d1ae47fd723572d57934c78/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{2-[3-(pyrimidin-2-yl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332165912](/st/structure/200/13369f34ee14650045e68c473c677457/C%253DCS%2528%253DO%2529%2528%253DO%2529NCCC1%253DNC%2528%253DNO1%2529C1%253DNC%253DCC%253DN1.png)
![Chemical structure of N-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]propyl}ethene-1-sulfonamide - CSSB21332126591](/st/structure/200/e71a724eaabd3771b3d909cf48ce302b/FC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528CCCNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DN1.png)
